Immunoengineering
Phagocytosis and Polarization
Simeon Williams, II, n/a
Undergraduate Student (Research)
Center for Engineering MechanoBiology at The University of Pennsylvania
St.Louis, Missouri, United States
Steven Phan
PhD Student
University of Pennsylvania, United States
Dennis E. Discher, PhD (he/him/his)
Robert D Bent Professor
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Figure 1 above shows the results of the phagocytosis assay performed with DMSO being the control and the first condition, along with nocodazole, which was the second condition.
Figure 2 above shows the results of the phagocytosis assay performed with the first condition which was the B16 media, and the second condition which was nocodazole.
It is extremely significant to highlight the function and relationship between these various drugs and both the macrophages and B16s. The first drug that was used and that acted as the control was DMSO or dimethyl sulfoxide. The second drug was nocodazole, which is a microtubule inhibitor. Nocodazole prevents the assembly of microtubules, and subsequently, the process of cell division which is vital to the B16s. Furthermore, these lower percentages of eating done by the macrophages of the B16s may be attributed to this toxic condition that nocodazole is for phagocytosis. In addition to these two drugs, B16 media served as another condition within this assay. This condition specifically yielded the most amount of eating, which made sense given the likelihood of the B16s dividing, therefore increasing the opportunity for the macrophages to engulf more of them.